We are live on ! Find out more
FSA

Franklin Street Advisors Portfolio holdings

AUM $1.79B
1-Year Est. Return 28.1%
This Fund
S&P 500
This Quarter Est. Return
+10.82%
1 Year Est. Return
+28.1%
3 Year Est. Return
+112.88%
5 Year Est. Return
+150.28%
10 Year Est. Return
+636.48%
AUM
$1.18B
AUM Growth
+$106M
Cap. Flow
-$3.92M
Cap. Flow %
-0.33%
Top 10 Hldgs %
39.39%
Holding
162
New
5
Increased
48
Reduced
62
Closed
2

Top Buys

Rank Stock Value
1
PARA
Paramount Global Class B
PARA
+$13.3M
2
DG icon
Dollar General
DG
+$10.3M
3
XOM icon
ExxonMobil
XOM
+$9.11M
4
KO icon
Coca-Cola
KO
+$7.42M
5
MCD icon
McDonald's
MCD
+$4.7M

Top Sells

Rank Stock Value
1
SBUX icon
Starbucks
SBUX
+$18.5M
2
VRSK icon
Verisk Analytics
VRSK
+$9.21M
3
LULU icon
lululemon athletica
LULU
+$7.99M
4
V icon
Visa
V
+$3.43M
5
CRM icon
Salesforce
CRM
+$3.02M

Sector Composition

Rank Sector Weight
1 Technology 24.79%
2 Financials 16.98%
3 Healthcare 12.82%
4 Communication Services 11.12%
5 Consumer Discretionary 11.06%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MRK icon
76
Merck
MRK
$316B
$1.08M 0.09%
13,918
-164
-1% -$12.2K
UNH icon
77
UnitedHealth
UNH
$377B
$1.05M 0.09%
2,611
-160
-6% -$63.8K
KKR icon
78
KKR & Co
KKR
$95.7B
$1.03M 0.09%
17,375
PEP icon
79
PepsiCo
PEP
$191B
$977K 0.08%
6,594
-474
-7% -$69.1K
WFC icon
80
Wells Fargo
WFC
$266B
$958K 0.08%
21,151
+1,054
+5% +$47.1K
PTGX icon
81
Protagonist Therapeutics
PTGX
$8.51B
$909K 0.08%
20,250
-2,000
-9% -$66K
ITW icon
82
Illinois Tool Works
ITW
$83B
$894K 0.08%
4,000
KMI icon
83
Kinder Morgan
KMI
$69.9B
$838K 0.07%
45,975
-685
-1% -$12.2K
INTC icon
84
Intel
INTC
$459B
$814K 0.07%
14,501
-260
-2% -$15.3K
COST icon
85
Costco
COST
$423B
$801K 0.07%
2,025
BCRX icon
86
BioCryst Pharmaceuticals
BCRX
$2.24B
$791K 0.07%
+50,000
New +$679K
GILD icon
87
Gilead Sciences
GILD
$163B
$769K 0.07%
11,164
-100
-0.9% -$6.68K
QCOM icon
88
Qualcomm
QCOM
$159B
$756K 0.06%
5,291
+217
+4% +$29.3K
COF icon
89
Capital One
COF
$134B
$726K 0.06%
4,693
+153
+3% +$23.1K
SYRE icon
90
Spyre Therapeutics
SYRE
$8.24B
$721K 0.06%
4,144
BMY icon
91
Bristol-Myers Squibb
BMY
$134B
$694K 0.06%
10,387
-2,170
-17% -$141K
SUPN icon
92
Supernus Pharmaceuticals
SUPN
$2.67B
$682K 0.06%
22,145
-2,000
-8% -$61.3K
PRQR icon
93
ProQR Therapeutics
PRQR
$241M
$674K 0.06%
100,000
SGMO
94
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
$655K 0.06%
54,710
+44,000
+411% +$498K
AMGN icon
95
Amgen
AMGN
$204B
$646K 0.05%
2,650
-50
-2% -$12.3K
EWT icon
96
iShares MSCI Taiwan ETF
EWT
$10.2B
$640K 0.05%
10,000
SO icon
97
Southern Company
SO
$107B
$640K 0.05%
10,584
+624
+6% +$39.9K
SBUX icon
98
Starbucks
SBUX
$118B
$634K 0.05%
5,668
-163,277
-97% -$18.5M
AEP icon
99
American Electric Power
AEP
$69.9B
$627K 0.05%
7,407
DOW icon
100
Dow Inc
DOW
$21.6B
$566K 0.05%
8,946

Similar funds

Franklin Street Advisors's Q2 2021 Portfolio in Review

As of Q2 2021, Franklin Street Advisors held 162 positions worth $1.18B, up 9.8% from $1.08B the previous quarter. Its ten largest holdings account for 39% of the portfolio.

Trading was light in Q2 2021: portfolio turnover was 4.3%. Franklin Street Advisors opened 5 new positions and exited 2, leaving the 162-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 24% a quarter earlier, followed by Financials and Healthcare.

  • Franklin Street Advisors's largest Q2 2021 buy was Paramount Global Class B: 322,557 shares worth $14.6M.
  • Franklin Street Advisors added most to Dollar General in Q2 2021, an estimated $10.3M increase.
  • Franklin Street Advisors's biggest Q2 2021 reduction was Starbucks, cutting an estimated $18.5M.
  • Franklin Street Advisors fully exited Clorox in Q2 2021, selling an estimated $233K.
  • Franklin Street Advisors's ten largest holdings make up 39% of its $1.18B portfolio in Q2 2021.
  • Franklin Street Advisors opened 5 new positions and closed 2 in Q2 2021.
  • Franklin Street Advisors's portfolio value rose 9.8% quarter-over-quarter to $1.18B.

Based on Franklin Street Advisors's 13F filing for Q2 2021, filed 5 Aug 2021.